Stockreport

The Bull Case For ACADIA Pharmaceuticals (ACAD) Could Change Following EMA Setback For Trofinetide Approval [Yahoo! Finance]

ACADIA Pharmaceuticals Inc.  (ACAD) 
Last acadia pharmaceuticals inc. earnings: 2/26 04:05 pm Check Earnings Report
PDF issued a negative trend vote on its Marketing Authorization Application for trofinetide to treat Rett syndrome, with Acadia planning to pursue a formal re-examination if [Read more]